Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate in PVR Grade C
NCT04482543Phase 3Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Aug 2020
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of methotrexate in Proliferative Vitreoretinopathy (PVR) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Retinal reattachment rate at 6 months. Status: unknown.
02
Drugs
methotrexate
03
Conditions
Proliferative Vitreoretinopathy (PVR)
Beyond the preview
Go deeper on NCT04482543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04482543.